Novosibirsk · Russian-qualified counsel Recognised by Pravo-300 · Best Lawyers · Kommersant
Cross-border Disputes

Client alert: Russian development affecting witness evidence collection in Russia for international arbitration in the pharmaceuticals sector

Vitaliy Vetrov · May 2026 · 3 min read

Witness evidence collection in Russia for international arbitration faces tighter controls. Pharma sector firms face heightened exposure. Make an enquiry.

Alert: Russian development affecting witness evidence collection in Russia for international arbitration in the pharmaceuticals sector Effective: October 2026

Russian courts and authorities have confirmed a stricter approach to witness evidence collection on Russian territory for use in international arbitral proceedings. Under Russian procedural rules, the gathering of witness statements in Russia for foreign proceedings must proceed through formal judicial assistance channels — bilateral treaty mechanisms or the Hague Convention on the Taking of Evidence. Recent practice indicates that statements obtained outside these channels are increasingly challenged, and Russian authorities have shown less tolerance for informal interview arrangements conducted on Russian soil, even where the instructing party is based abroad.

Pharmaceutical companies with Russian operations face a compounded risk. Employees in medical affairs, pharmacovigilance, and regulatory affairs may hold information subject to Russian pharmaceutical confidentiality obligations. Participation in witness preparation sessions — including interviews conducted remotely or outside Russia — can, in certain circumstances, expose those individuals to domestic legal liability if the information concerned is treated as commercially or regulatorily sensitive under Russian law. This risk applies whether the company is a claimant or respondent in international arbitral proceedings, and is not resolved simply by conducting the interview in a third jurisdiction.

For in-house counsel at pharmaceutical companies with Russian operations or Russian contractual counterparties, the recommended steps are as follows: 1. Identify prospective witnesses at Russian-resident entities at the earliest stage of arbitral proceedings and assess their regulatory exposure before any witness preparation begins. 2. Confirm the applicable judicial assistance channel — treaty route or Hague Convention — and initiate the request well in advance of relevant procedural deadlines, as processing timelines in Russia can be lengthy. 3. Seek specific advice on the treatment of pharmaceutical regulatory data, trade secrets, and employee obligations under Russian law before any document or statement is sought from Russian-based personnel.

For in-house counsel managing Russian-facing arbitration, establishing the correct evidence collection route before proceedings advance is a procedural priority. Make an enquiry: info@vetrovpartners.com |

— Vitaliy Vetrov Managing Partner, Vetrov & Partners vetrovpartners.com/vetrov/

Practitioner note

This briefing is general information and does not constitute legal advice. For advice on a specific matter, write in confidence to info@vetrovpartners.com.

Facing a matter like this?

Our team advises foreign clients on exactly these questions across Russia and the EAEU region. Initial 30-minute consultation — complimentary.

Make an enquiry